ARSA (Search Result) Help

Search Result

Facet

Division

now loading

    Organism_facet

    now loading

      List of Entries

      1 - entries / Number of founds: 124  
        PrimaryAccessionNumber Definition SequenceLength MolecularType Organism
      N22566 yw30f06.s1 Morton Fetal Cochlea Homo sapiens cDNA clone IMAGE:253763 3', mRNA sequence. 584 mRNA Homo sapiens
      DJ151946 JP 2007228956-A/22564: Method for identification of useful proteins derived from brewery yeast. 25 DNA Saccharomyces pastorianus
      MC164410 JP 2019500349-A/22566: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES. 18 RNA synthetic construct
      MC551066 JP 2019525738-A/22566: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES. 5 PRT synthetic construct
      MD754808 JP 2019507579-A/22566: MATERIALS AND METHODS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY. 20 DNA synthetic construct
      OG506752 JP 2018534252-A/22566: PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF. 32 PRT synthetic construct
      HZ527347 JP 2016501039-A/22566: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS. 40 DNA synthetic construct
      MD268699 JP 2020517247-A/22566: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof. 20 DNA synthetic construct
      DL904310 JP 2014205669-A/22566: Method of constructing and screening libraries of peptide structures. 26 PRT synthetic construct
      MC774676 JP 2018525446-A/22566: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF. 34 PRT synthetic construct
      DJ952927 JP 2010500568-A/39608: ORGAN-SPECIFIC PROTEINS AND METHODS OF THEIR USE. 653 PRT Homo sapiens
      MC906304 JP 2018536623-A/22566: PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF. 39 PRT synthetic construct
      DM759260 JP 2014079248-A/22566: NEISSERIAL ANTIGENIC PEPTIDES. 5 PRT Neisseria
      PA527050 JP 2022502046-A/9832: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY. 21 DNA synthetic construct
      PA393289 JP 2021533803-A/22372: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE. 26 DNA Homo sapiens
      PA338214 JP 2021522188-A/22566: Compositions and Methods for Multiplexed Tumor Vaccination with Endogenous Gene Activation. 20 DNA synthetic construct
      MB763499 JP 2018535655-A/27396: ASGR INHIBITORS. 8 PRT synthetic construct
      OG752085 JP 2021120380-A/22566: CANCER NEOEPITOPES. 9 PRT Homo sapiens
      DJ526366 JP 2010517930-A/22566: Method of constructing and screening libraries of peptide structures. 26 PRT synthetic construct
      DM797024 JP 2014068652-A/22566: NEISSERIAL ANTIGENIC PEPTIDES. 5 PRT Neisseria
      PD710480 JP 2021530475-A/22562: De novo Design of Protein Switches. 59 PRT synthetic construct
      LF829722 JP 2016528161-A/22555: COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS. 18 RNA synthetic construct
      LF681787 JP 2016521556-A/22566: COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION. 15 DNA Homo sapiens
      DD549169 JP 2004508801-A/22566: NEISSERIAL ANTIGENIC PEPTIDES. 5 PRT Neisseria
      DL031580 JP 2005512499-A/22566: Diagnosis of existing illnesses or that praedisposition for determined illnesses. 588 DNA synthetic construct
      LV568388 JP 2017029159-A/22566: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS. 40 DNA synthetic construct
      HW187594 JP 2013102767-A/22518: Novel siRNA's and Use Thereof. 21 RNA synthetic construct
      DL613168 JP 2011092200-A/22566: NEISSERIAL ANTIGENIC PEPTIDES. 5 PRT Neisseria
      HV879107 JP 2010507387-A/22518: Novel siRNAs and Methods of Use Thereof. 21 RNA synthetic construct
      LX120182 JP 2017506877-A/22564: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes. 16 DNA synthetic construct
      Now loading
      PAGE TOP